Regulatory Reforms Propel India’s Diabetes Market: DPCO Price...

adicionou um novo artigo Health

2025-11-14 06:24:40 -

Regulatory Reforms Propel India’s Diabetes Market: DPCO Price Caps and Biosimilar Approvals Boost Access

India’s regulatory environment is a key driver of its diabetes market growth, with recent reforms aimed at improving affordability and accelerating innovation. The 2023 Drug Price Control Order (DPCO) now caps prices on 120+ essential diabetes drugs, including metformin, gliclazide, and insulin, reducing out-of-pocket expenses for patients by an estimated 30%. Meanwhile, the DCGI’s...

0 Comentários 0 Compartilhamentos 35 Visualizações 0 Anterior